Initiative hopes to expedite cell-based treatments for Parkinson's

Nov 23, 2010
Initiative hopes to expedite cell-based treatments for Parkinson's
In cell transplantation procedures for PD, undamaged dopaminergic neurons (shown here in red, with other neurons in green) are used to replenish those that are lost or dying. Credit: Rocio Laguna Goya, Centre for Brain repair

 ( -- A unique initiative which brings together some of the world’s leading Parkinson’s researchers, aims to reduce further delays in using cells to treat Parkinson’s disease. The initiative will focus on refining cell-based therapy, which replaces the diseased cells with healthy cells.

Although the technique for using cell-based therapy to treat Parkinson's has been around for over two decades, it has had dramatically varying outcomes. After treatment, some patients have been able to go drug-free with markedly improved symptoms and signs for many years. Other patients develop side effects from the treatment which can cause further distress and problems.

Researchers in this field recognised that there was a lack of consistency in previous trials as to when the treatment was administered (patients were of varying ages, different stages of the disease, etc). This prompted these experts to launch an initiative to examine why some procedures are successful and others are not. By reassessing the earlier trials, they intend to put together a protocol to increase the likelihood of success.

"There has been huge variability in patients' stage of disease and medication history; the clinical techniques used for cell delivery; the viability and durability of the cells being transplanted; and even in how outcomes were measured. It's easy to see how difference in average improvement could be obscured within the data," says Dr Roger Barker from the Centre for Brain Repair at the University of Cambridge, who is leading the programme.

Dr Barker will head the five-year research programme called TRANSEURO, which brings together experts from 13 institutions across five European countries and will also work closely with American research groups. TRANSEURO aims to coordinate research methods in order to develop safer and more reliable practices for cell transplantation in patients with .

"Our goal is to provide the impetus to push the field ahead to a new phase of cell therapy trial in Parkinson's disease," says Dr. Roger Barker.

Parkinson's disease affects 1% of adults over the age of 65, and is incurable. It causes the death of the brain cells including those that produce Dopamine, a chemical which is required by the brain to carry out ordinary activities such as voluntary movement and cognition.

Since the 1970s, scientists have been experimenting with new ways to replace the lost cells in order to alleviate some of the most severe symptoms of Parkinson's disease, and their results have been highly variable. Whilst in some cases trials have led to significant improvements in the condition of patients, in others the therapy has failed, causing side effects requiring further surgery. Trials ceased at the beginning of this century after two in the United States concluded there was no major benefit to cell transplantation in Parkinson's disease.

However, scientists believe that transplantation is still the way forward for treatment of this disease. Dr. Barker and colleagues believe that data from these earlier trials holds information that was previously overlooked, and part of the TRANSEURO programme will involve reassessing this data with the help of experts involved in the previous trials.

Additionally, developments in the understanding of Parkinson's disease within the last decade have enabled researchers to identify sub-types of the disease, and this could prove key in establishing better transplant criteria, and identifying optimum patient groups. TRANSEURO will also investigate the of the transplant procedure.

But the use of foetal tissues, stem cells, and other emerging cell based therapies are not without controversy, and work of this type often raises many ethical issues. It is for this reason that a separate project will run alongside the scientific and clinical work to consider the ethical questions posed.

It is anticipated the programme will eventually recruit at least 150 patients from across the TRANSEURO network, of which 20 will be entered into the first set of transplant trials in 2011/12. It is expected that the study will pave the way for larger trials in which the transplant cells will eventually be derived from stem cells.

"We regard TRANSEURO as a stepping stone that will refine the clinical methods needed for any kind of cell-based therapy, whatever the source of cells," says Barker. And whilst this will not actually cure the disease, such treatments would be invaluable to those affected.

"Reparative strategies used early in the disease could have the potential to give patients many drug-free years, which would be a major therapeutic step forward."

TRANSEURO is not currently recruiting patients for the trial as ethical approvals are not yet in place. The programme's main funders include Parkinson's UK, Cure PD and the European Union (FP7 grant).

Explore further: Know the brain, and its axons, by the clothes they wear

add to favorites email to friend print save as pdf

Related Stories

Skin cells could help discover cause of Parkinson's disease

Jul 14, 2010

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease, the UK National Stem Cell Network (UKNSCN) annual science meeting ...

Creatine Parkinson trial begins

Mar 26, 2007

A large-scale national clinical trial has started to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease.

Stem cell research aims to tackle Parkinson's disease

Jan 18, 2008

Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinson’s disease, an international conference of biologists organised by the European ...

New stem cell research unlocks unknown therapies

May 21, 2009

New treatments for the devastating Parkinson's disease and ALS are in clinical studies in Sweden, thanks to breaking new stem cell research. This news was presented today by Dr. Jonas Frisen, Professor of stem cell research ...

Recommended for you

Know the brain, and its axons, by the clothes they wear

Apr 18, 2014

(Medical Xpress)—It is widely know that the grey matter of the brain is grey because it is dense with cell bodies and capillaries. The white matter is almost entirely composed of lipid-based myelin, but ...

Turning off depression in the brain

Apr 17, 2014

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Rapid whole-brain imaging with single cell resolution

Apr 17, 2014

A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to ...

User comments : 0

More news stories

Filipino tests negative for Middle East virus

A Filipino nurse who tested positive for the Middle East virus has been found free of infection in a subsequent examination after he returned home, Philippine health officials said Saturday.

Study says we're over the hill at 24

(Medical Xpress)—It's a hard pill to swallow, but if you're over 24 years of age you've already reached your peak in terms of your cognitive motor performance, according to a new Simon Fraser University study.

NASA's space station Robonaut finally getting legs

Robonaut, the first out-of-this-world humanoid, is finally getting its space legs. For three years, Robonaut has had to manage from the waist up. This new pair of legs means the experimental robot—now stuck ...

Ex-Apple chief plans mobile phone for India

Former Apple chief executive John Sculley, whose marketing skills helped bring the personal computer to desktops worldwide, says he plans to launch a mobile phone in India to exploit its still largely untapped ...

Egypt archaeologists find ancient writer's tomb

Egypt's minister of antiquities says a team of Spanish archaeologists has discovered two tombs in the southern part of the country, one of them belonging to a writer and containing a trove of artifacts including reed pens ...

Airbnb rental site raises $450 mn

Online lodging listings website Airbnb inked a $450 million funding deal with investors led by TPG, a source close to the matter said Friday.